|


    
| |
Chief editor
Abdulrazak Abyad MD, MPH, MBA, AGSF, AFCHSE
Editorial office:
Abyad Medical Centre & Middle East Longevity Institute
Azmi Street, Abdo Centre
PO Box 618
Tripoli, Lebanon
Tel: 961 6 443 684
Fax: 961 6 443 685
aabyad@cyberia.net.lb
Publisher
Lesley Pocock
medi+WORLD International
572 Burwood Road,
Hawthorn 3122, VIC
Australia
Tel: +61 3 9819 1224
Fax: +61 3 98193269
Lesleypocock@mediworld.com.au
|
|
|
While all efforts have been
made to ensure the accuracy of the information in this journal,
opinions expressed are those of the authors and do not necessarily
reflect the views of The Publishers, Editor or the Editorial
Board. The publishers, Editor and Editorial Board cannot be
held responsible for errors or any consequences arising from
the use of information contained in this journal; or the views
and opinions expressed. Publication of any advertisements
does not constitute any endorsement by the Publishers and
Editors of the product advertised.
The contents of this journal
are copyright. Apart from any fair dealing for purposes of
private study, research, criticism or review, as permitted
under the Australian Copyright Act, no part of this program
may be reproduced without the permission of the publisher.
|
|
|
|
May
2009, Volume
6 - Issue 3
|
|
Editorial
Editor: Abdulrazak Abyad
|
|
In
this issue Dr Dadkhah A, looked at the service framework
for older people in Japan. The author stressed that
developed countries have thought and planned for population
aging, but if the developing countries do not think
about programming for health services of aged people,
in the near future they will encounter socioeconomic
and health crises. The author stressed that developing
nations can learn a lot from the Japanese model of care.
A paper from Saudi Arabia looked
at lessons from trials. The author stressed that a lot
of trials have been published recently discussing the
benefits of intensive glucose control versus conventional
glucose control. One of these studies was the 10 - year
follow - up of intensive glucose control in type 2 diabetes
published in the New England Journal of Medicine in
October 2008. Although this study reached interesting
findings, the number of deaths during this study was
too high (1,851 deaths out of 3,277 participants during
10 years). The contrast between the benefits and number
of deaths force us to ask this question: Do we need
all these deaths?
A paper from Jordan looked at
the Value of HbA1c Testing in Diabetic Patients. The
aim of the author was to investigate whether HbA1c testing
can be used a predictor for the presence of diabetic
retinopathy as an example of long term diabetic complications.
A prospective study was conducted at Prince Ali Hospital
in Southern Jordan. on 120 diabetic patients attending
internal medicine clinic were investigated for their
HbA1c level. The mean age of patients was 59.3 years.
Forty patients were found to have diabetic retinopathy;
thirty of them had non-proliferative changes and ten
had proliferative retinopathy. HbA1c of more than 9%
was associated with the most severe form of retinopathy.
The author concluded that HbA1c measurement is a useful
test for predicting and monitoring the risk of progression
of diabetic retinopathy as an example of longterm diabetic
complications
A paper from Bangladesh attempted
to determine if I/A Methotrexate is effective in rheumatoid
arthritis.
This study was conducted in medical B unit of Postgraduate
Medical Institute, Lady Reading hospital and a private
rheumatology clinic in Peshawar.
A total of 40 rheumatoid arthritis patients who were
resistant to I/A steroids were included in the study.
A total of 28 patients completed two follow ups, one
for re-injection and the other for response analysis.
The authors concluded that the response rate was 6/28
(21.42%), which is encouraging, besides the patients
received only two injections of I/A MTX whuch was much
better than reported in a few studies from abroad. It
is the first ever study on I/A Methotrexate from NWFP
and probably from Pakistan.
A paper from Iran looked at
whether preoperative quality of life predicts adverse
outcomes of coronary artery bypass graft surgery in
the elderly? Seventy one patients ranging from 60 to
80 years old and who underwent pure CABG were consecutively
studied. Patients' quality of life (QOL) was assessed
before surgery by using SF-36 questionnaire. Postoperative
early complications were also considered. The authors
concluded that patients older than 60 years have poor
physical role and appropriate social function before
CABG, however different aspects of QOL before cardiac
surgery may not influence postoperative early outcome.
|
|
|
|